AAIPharma Services, Cambridge merger called Alcami

AAIPharma Services, Cambridge merger called Alcami

9:58 AM, 22nd March 2016
AAIPharma Services, Cambridge merger called Alcami

WILMINGTON, US: AAIPharma Services Corporation (AAI) / Cambridge Major Laboratories Inc (CML) has announced its new brand and identity name as “Alcami.” It will be a leading contract development and manufacturing organization (CDMO) with expanded capabilities and capacity.

Originally joined together in late 2013, AAI and CML combined to offer analytical testing and development services for active pharmaceutical ingredients (APIs) with oral solid and parenteral dose finished product capacity. Providing an integrated offering for both drug substance and drug product at every development stage beginning with solid state chemistry and formulation development, Alcami believes they have created a robust new outsourcing offering.

Alcami has recently announced significant investments in additional capabilities and capacity for oral solid dose manufacturing, and parenteral fill-finish capabilities and capacity, including additional sterile lines and lyophilization capacity available now.

Alcami will be relocating its current St Louis Analytical Testing Services to a new state of the art facility at the Cortex Innovation Center in St Louis, US, which provides innovative analytical testing solutions for manufacturers’ new drug entities, generic drugs, animal health products, medicated consumer health products, chemicals and biopharmaceuticals.

“With nearly 1000 employees at seven sites in the US and Europe, these upgrades across our facilities in Wilmington, Charleston, Durham, Germantown, Edison, St Louis, and Weert, the Netherlands, combined with enhancements in our quality, execution and customer focus, support the overall progress of our growth strategy as a contract services provider with a renewed commitment to meeting customer needs like never before. With increases in our capabilities and capacities across all our businesses, our ability to serve the market is stronger than ever,” said Stephan Kutzer, CEO, Alcami.

© Worldofchemicals News

Management related news:

AAIPharma, Cambridge Major Laboratories appoint new CEO, Stephan Kutzer 



Your Comments (Up to 2000 characters)
Please respect our community and the integrity of its participants. WOC reserves the right to moderate and approve your comment.

Related News

Sherwin-Williams acquires Valspar for $9.3 billion in cash

CLEVELAND & MINNEAPOLIS, US: The Sherwin-Williams Company and The Valspar Corporation have agreed for Sherwin-Williams to acquire Valspar for $113 ...

Read more
BASF supports Pfluger to develop new window and door installation

LIMBURGERHOF, GERMANY: Pfluger TOB GmbH, which is based in Obersteinach, Germany, offers a new generation of windowsill connection profiles, substruct ...

Read more
First time around BASF produces binders for interior paints

LIMBURGERHOF, GERMANY: For the first time ever BASF SE is producing dispersions for interior paints based on the mass balance approach. To manufacture ...

Read more
Saudi Aramco, Shell to unwind assets of refining, marketing JV Motiva

DHAHRAN, SAUDI ARABIA: Saudi Aramco through its wholly owned subsidiary Saudi Refining Inc (SRI) and Royal Dutch Shell plc (Shell), through its US dow ...

Read more
Lanxess, Saudi Aramco rubber JV ARLANXEO names executive board

COLOGNE, GERMANY: Lanxess AG and Saudi Aramco have announced the members of the executive board of ARLANXEO, their 50:50 synthetic rubber joint ventur ...

Read more
BASF files for registration of new fungicide Revysol with European Union

LIMBURGERHOF, GERMANY: BASF SE has submitted the regulatory dossier for a new active ingredient, Revysol, to the European Union (EU). The proprietary ...

Read more
www.worldofchemicals.com uses cookies to ensure that we give you the best experience on our website. By using this site, you agree to our Privacy Policy and our Terms of Use. X